Integrum AB (publ) (FRA:6Y1)

Market Cap	21.20M -73.8%
Revenue (ttm)	8.85M -1.4%
Net Income	-4.27M
EPS	-0.18
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.7450
Previous Close	0.7340
Day's Range	0.7450 - 0.7450
52-Week Range	0.5880 - 3.9050
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 3, 2026

About Integrum AB

Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads. It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputa...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1990
• Employees: 34
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 6Y1

Financial Performance

In fiscal year 2026, Integrum AB's revenue was 96.14 million, a decrease of -1.42% compared to the previous year's 97.52 million. Losses were -46.34 million, 50.4% more than in 2025.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 27, 2026

Data Sources Report a data error